- Lobbying
- burrell AND international AND group
Lobbying Arrangements Results for 'Burrell International Group'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details National Guard Funding and Defense Appropriations |
O'Brien Gentry & Scott LLC (on behalf of Cocoon)
|
Burrell International Group LLC | |||
Details Defense Appropriation for Prosthetic Research for Infection Treatment and Prevention |
Garwood Medical Devices LLC
|
Burrell International Group LLC | |||
Details Defense Policy & Acquisition; Homeland Security and USCG Modernization |
O'Brien Gentry & Scott LLC (on behalf of Avlite Systems)
|
Burrell International Group LLC | |||
Details Support for Next generation diagnostics for CBRN |
Hememics Biotechnologies, Inc.
|
Burrell International Group LLC | |||
Details Payment Technology Socialization and compliance technology |
FlowPay Corporation
|
Burrell International Group LLC | |||
Details NDAA and Defense Appropriations for Cyber-Security and small business 8(A) Program |
Goldbelt Inc.
|
Burrell International Group LLC | |||
Details Pandemic and All Hazard Preparedness Act, FY24 Defense and Labor HHS for next generation blood products |
Cellphire, Inc.
|
Burrell International Group LLC | |||
Details Next gen medical countermeasures in the NDAA and Defense Appropriations legislation. |
BioFactura, Inc.
|
Burrell International Group LLC | |||
Details Accessible mobile technology policy |
Sesame Enable, Inc
|
Burrell International Group LLC | |||
Details Funding for portable oxygen generation systems; No specific legislation at this time. |
Oxygenium Inc.
|
Burrell International Group LLC | |||
Details Funding for Genetic Testing, women's health, NDAA, and carrier screening |
Otogenetics
|
Burrell International Group LLC | |||
Details Covid 19 Stimulus funding, biotechnology, LHHS Appropriations for NIH and BARDA diagnostic funding Committees: Appropriations |
APCO Worldwide LLC (on behalf of DetectNow f/k/a Homodeus Detect) )
|
Burrell International Group LLC | |||
Details Diagnostic and small business research and development |
Small Biotechnology Business Coalition
|
Burrell International Group LLC | |||
Details Department of Transportation Artificial Intelligence solutions for asset management. FY22 THUD appropriations and AI policy. |
Dynamic Infrastructure
|
Burrell International Group LLC | |||
Details Automated Vehicle Policy and Transportation Policy for smart cities. |
STEER Tech
|
Burrell International Group LLC | |||
Details FY24 Defense Appropriation and NDAA for munitions demilitarization; Defense Production Act |
Gradient Technology
|
Burrell International Group LLC | |||
Details Funding for medical devices for hemorrhages; provisions in FY24 NDAA and FY24 Defense Appropriations |
Burrell International Group (on behalf of Arsenal Medical, Inc.)
|
TRUSYNERGY | |||
Details Drug pricing, gene therapy, and rare disease funding generally; Advancing Access to Precision Medicine; Newborn Screening Saves Lives Reauthorization Act; Genome Editing Threat Assessment Act; Medi... |
Homology Medicines
|
Burrell International Group LLC | |||
Details Counter Unmanned Aerial Systems Appropriation |
Obrien Gentry & Scott LLC (on Behalf of Elta N.A.)
|
Burrell International Group LLC | |||
Details Medical device and Traumatic Brain Injury funding |
O'Brien Gentry & Scott LLC (on behalf of Q30 Innovations LLC)
|
Burrell International Group LLC | |||
Details National Defense Authorization Act; Department of Defense Appropriations; Defense Policy and Acquisition Matters |
O'Brien Gentry & Scott LLC (On behalf of Tactical Lighting Systems
|
Burrell International Group LLC | |||
Details NDAA - provisions related to biological and chemical defense Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guidelines |
Emergent Biosolutions, Inc. (F/K/A Adapt Pharma Inc.)
|
Burrell International Group LLC | |||
Details Medical Countermeasures Development of Therapeutics for COVID-19 and Rare Disease |
Avalo Therapeutics
|
Burrell International Group LLC | |||
Details Pandemic and All Hazards Preparedness Act, FY24 LHHS Funding for MCM Development; H.R.2940/S.1355.PASTEUR Act of 2023 |
Shionogi Inc.
|
Burrell International Group LLC | |||
Details COVID-19 therapeutics and Medical Countermeasures, Rare Disease, and Re-purposed drugs; Defense Appropriations for MCM Development |
Acer Therapeutics
|
Burrell International Group LLC | |||
Details Defense policy and acquisition. |
O'Brien Gentry & Scott LLC (on behalf of DSG Technology)
|
Burrell International Group LLC | |||
Details Labor/HHS Appropriation - SNS Funding and DoD Appropriation - TBI Biomarker, OTC Test Coverage, PAHPA. |
APCO Worldwide LLC (on behalf of QuidelOrtho)
|
Burrell International Group LLC | |||
Details Defense Appropriations for Cyber and Mission Assurance, 8(a) Native Hawaiian Organization Policy |
Pacific Technologies and Solutions
|
Burrell International Group LLC | |||
Details DoD Appropriation for Research and Development for hemorrhage control |
Arsenal Medical, Inc.
|
Burrell International Group LLC | |||
Details LHHS Appropriation R&D Funding, Pandemic Preparedness Funding for Next Generation Products |
Tonix Pharmaceuticals Holding Corp.
|
Burrell International Group LLC | |||
Details Advancement of novel anti-tumor technology |
Ervin Graves Strategy LLC on behalf of Immunicom Inc
|
Burrell International Group LLC | |||
Details Government support for COVID-19 vaccine development and production, advancement of unique vaccine and gene therapy delivery vector. |
Ervin Graves Strategy on behalf of Greffex Inc.
|
Burrell International Group LLC | |||
Details Defense Appropriations Act for Fiscal Year 2022 - ultra-long medicine delivery platform; National Defense Authorization Act for Fiscal Year 2022 - ultra-long medicine delivery platform; Labor Healt... |
Ervin Graves Strategy on behalf of Lyndra Therapeutics fka Ervin Hill Strategy
|
Burrell International Group LLC | |||
Details Oversight of the Strategic National Stockpile to promote safer and more effective treatments in the stockpile; PASTEUR Act; reauthorization of the Pandemic and All Hazards Preparedness Act; FY 24 L... |
Burrell International Group LLC (on behalf of Shionogi Inc.)
|
TRUSYNERGY | |||
Details Generate advocacy for the expansion of domestic infant formula manufacturing; House and Senate Appropriations Availability of domestic supply chain materials, mother and baby nutrition; FY 24 Appro... |
Ervin Graves Strategy LLC on behalf of ByHeart Inc
|
Burrell International Group LLC |